Cargando…
Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments
Resistance to chemotherapy is a current clinical problem, especially in the treatment of microbial infections and cancer. One strategy to overcome this is to make new derivatives of existing drugs by conjugation to organometallic fragments, either by an appropriate linker, or by direct coordination...
Autores principales: | Chellan, Prinessa, Sadler, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496994/ https://www.ncbi.nlm.nih.gov/pubmed/32452579 http://dx.doi.org/10.1002/chem.201904699 |
Ejemplares similares
-
The elements of life and medicines
por: Chellan, Prinessa, et al.
Publicado: (2015) -
Actinide Organometallic Complexes with π‐Ligands
por: Walter, Olaf
Publicado: (2018) -
Enhancement of Selectivity of an Organometallic Anticancer
Agent by Redox Modulation
por: Romero-Canelón, Isolda, et al.
Publicado: (2015) -
Antibody-drug conjugates—an emerging class of cancer treatment
por: Diamantis, Nikolaos, et al.
Publicado: (2016) -
Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
por: Staudacher, Alexander H, et al.
Publicado: (2017)